Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression

Science in China, Series C: Life Sciences

Volumn 51, Issue 5, 2008, Pages 418-429

  Ou, Xiang ^a,b   Dai, XiaoYan ^a   Long, ZhiFeng ^a   Tang, YaLing ^a   Cao, DongLi ^a   Hao, XinRui ^a   Hu, YanWei ^a   Li, XiaoXu ^a   Tang, ChaoKe ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b SHAOGUAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Liver X receptor agonist; Niemann Pick C1 protein; Plaque

Indexed keywords

APOLIPOPROTEIN E; CELL RECEPTOR; DNA BINDING PROTEIN; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; NPC1 PROTEIN, MOUSE; PRIMER DNA; PROTEIN; SULFONAMIDE;

ANIMAL; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOHISTOCHEMISTRY; INTESTINE; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; INTESTINES; LIVER; MALE; MICE; MICE, KNOCKOUT; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SULFONAMIDES; UP-REGULATION;

MUS; TRIFLUORO;

EID: 43149089601     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-008-0054-4     Document Type: Article

References (36)

1. Ira T. Cholesterol and phospholipids metabolism in macrophages. Biochim Biophys Acta, 2000, 1529(1-3): 164-174
2. Tang C K, Yi G H, Yang J H, et al. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. Acta Pharmacol Sin, 2004, 25(5): 581-586
3. Jessica P, Laura L. Flux of fatty acids through NPC1 lysosomes. J Biol Chem, 2005, 280(11): 10333-10339
4. Yuki O, Yuko S, Michitaka S, et al. Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1/Vps4. Cell Sci, 2006, 119(13): 2643-2653
5. Ou X, Tang C K. Roles of NPC1 and NPC2 in intracellular lipid homeostasis. Chin J Pathophysiol (in Chinese), 2007, 23(4): 820-824
6. Nobutaka O, Dennis C K, Matthew T, et al. Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Proc Natl Acad Sci USA, 2004, 101(34): 12473-12478
7. John M D, Stephen D T. Control of cholesterol turnover in the mouse. J Biol Chem, 2002, 277(6): 3801-3804
8. Stacie K L, Jill A M, Eugene D C, et al. Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science, 1997, 277(5323): 232-235
9. Laura L. Niemann-Pick type C mutations cause lipid traffic jam. Traffic, 2000, 1(3): 218-225
10. Catherine S, Maureen E H, Joanna P D, et al. Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain. J Biol Chem, 2004, 279(46): 48214-48223
11. Cheruku S R, Zhi X, Roxanne D, et al. Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J Biol Chem, 2006, 281(42): 31594-31604
12. Rigamonti E, Helin L, Lestavel S, et al. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res, 2005, 97(7): 682-689
13. Chen D Y, Jeffrey G M, Patel A, et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem, 2006, 281(38): 27816-27826
14. Tang C K, Xi S M, Yin W D, et al. Change of ATP binding cassette transporter A1 expression in diabetic minipigs. Prog Biochem Biophys (in Chinese), 2004, 31(6): 543-549
15. Asha V, Bryan A L, Sean B J, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. Proc Natl Acad Sci USA, 2000, 97(22): 12097-12102
16. Bradley M N, Hong C, Chen M, et al. Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE. J Clin Invest, 2007, 117(8): 2337-2346
17. Toshimori I, Morihiro M, Mitsuru S, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem, 2003, 278(24): 21344-21351
18. Choe S S, Choi A H, Lee J W, et al. Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis, liver X receptor-mediated lipotoxicity in pancreatic β-cells. Diabetes, 2007, 56(6): 1534-1543
19. Tang C K, Tang G H, Yi G H, et al. Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells. Acta Biochim Biophys Sin, 2004, 36(3): 218-226
20. Tang C K, Yang J H, Yi G H, et al. Effects of oleate on ATP binding cassette transporter A1 expression and cholesterol efflux in THP-1 macrophage derived foam cell. Acta Biochim Biophys Sin (in Chinese), 2003, 35(12): 1077-1082
21. Cha J Y, Repa J J. The liver X receptor (LXR) and hepatic lipogenesis: The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem, 2007, 282(1): 743-751
22. Emi K, Morihiro M, Yukio Y, et al. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem, 2003, 278(38): 36091-36098
23. -/- mice. Acta Biochim Biophys Sin, 2008, 40(3): 261-268
24. Wengen C, Yu S, Carrie W, et al. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late Endosomes/Lysosomes. J Biol Chem, 2001, 276(47): 43564-43569
25. Rajendra K T, Eric D B, Sean B J, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA, 2002, 99(18): 11896-11901
26. Sean B J, Elaine M, Liming P, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA, 2002, 99(11): 7604-7609
27. Bruemmer D, Law R E. Liver X Receptors: Potential novel targets in cardiovascular diseases. Current Drug Targets-Cardiovascular & Haematological Disorders, 2005, 5(6): 533-540
28. Whitney K D, Watson M A, Goodwin B, et al. Liver X receptor regulation of the LXRα gene in human macrophages. J Biol Chem, 2001, 276(47): 43509-43515
29. Ulven S M, Dalen K T, Gustafsson J A, et al. Tissue-specific autoregulation of the LXRα gene facilitates induction of apoE in mouse adipose tissue. J Lipid Res, 2004, 45(11): 2052-2062
30. Boadu E, Choi H Y, Lee D W K, et al. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J Biol Chem, 2006, 281(48): 37081-37090
31. -/- mice. Circulation, 2007, 116(21): 2444-2452
32. Jiang X C, Thomas P B, Li Z Q, et al. Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression. J Biol Chem, 2003, 278(49): 49072-49078
33. Hong Y C, Barbara K, Teddy C, et al. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem, 2003, 278(35): 32569-32577
34. -/- mice fed a high-fat/high-cholesterol diet. Inflammation, 2007, 30(3-4): 105-117
35. Peter T, David J M. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol, 2003, 17(6): 985-993
36. Joshua R S, Tu H, Alvin L, et al. Role of LXRs in control of lipogenesis. Genes Dev, 2000, 14(22): 2831-2838